Propafenone Therapy
Propafenone Therapy is an antiarrhythmic treatment modality that belongs to the class of sodium channel-blocking pharmacological interventions and is distinguished by its use of propafenone, a class 1C antiarrhythmic agent, to suppress cardiac arrhythmias through voltage-dependent inhibition of fast sodium currents.
384
Publications
16.7K
Citations
1.5K
Authors
431
Institutions
Publications per year
2017–2026
15
Parents
384
1–5 of 384
1.5K
10
h-index
10
h-index
9
h-index
9
h-index
7
h-index
1–5 of 1.5K
431
University of Vienna
Vienna, Austria
13 h-index
59 publications
1.8K citations

University of Bologna
Bologna, Italy
13 h-index
56 publications
4.1K citations
Universidad Complutense de Madrid
Madrid, Spain
11 h-index
49 publications
1.3K citations
Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology
Stuttgart, Germany
9 h-index
31 publications
771 citations
Medical University of Vienna
Vienna, Austria
8 h-index
18 publications
1K citations
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola
Bologna, Italy
7 h-index
25 publications
3K citations
Ospedale Sant'Anna
Como, Italy
7 h-index
35 publications
2.7K citations

Brigham and Women's Hospital
Boston, United States
7 h-index
24 publications
2.2K citations
1–8 of 431
56 publications · 3.4K citations
37
h-index
PACE · 23 publications · 708 citations
17
h-index
JACC · 18 publications · 1.1K citations
17
h-index
Repository · 34 publications · 738 citations
17
h-index
AHJ · 17 publications · 419 citations
14
h-index
1–5